The SAFE strategy for trachoma control: Using operational research for policy, planning and implementation

Bulletin of the World Health Organization

Volumn 84, Issue 8, 2006, Pages 613-619

  Emerson, Paul M ^a   Burton, Matthew ^b   Solomon, Anthony W ^b   Bailey, Robin ^b   Mabey, David ^b  

^a CARTER CENTER   (United States)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; TETRACYCLINE;

ANTIBIOTICS; BACTERIAL DISEASE; BLINDNESS; HOSPITAL SECTOR; HYGIENE; POLICY IMPLEMENTATION; POLICY MAKING;

BLINDNESS; CLEANING; CLINICAL RESEARCH; CLINICAL TRIAL; DISEASE CONTROL; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; ENVIRONMENTAL SANITATION; EVIDENCE BASED MEDICINE; HEALTH CARE PLANNING; HEALTH CARE POLICY; HEALTH PROGRAM; HUMAN; REVIEW; SINGLE DRUG DOSE; TRACHOMA; TRICHIASIS; WORLD HEALTH ORGANIZATION;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; ENVIRONMENT; HEALTH POLICY; HUMANS; HYGIENE; TRACHOMA; WORLD HEALTH ORGANIZATION;

EID: 33748375874     PISSN: 00429686     EISSN: 15640604     Source Type: Journal    
DOI: 10.2471/BLT.05.28696     Document Type: Review

References (46)

1. Resnikoff S, Pascolini D, Etya'ale D, Kocur I, Pararajasegaram R, Pokharel GP, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82:844-51.
2. Thylefors B. Prevention of blindness - WHO's mission for vision. World health forum 1998;19:53-9.
3. Bailey RL, Arullendran P, Whittle HC, Mabey DC. Randomised controlled trial of single-dose azithromycin in treatment of trachoma. Lancet 1993;342:453-6.
4. World Health Organization. Prevention of blindness and deafness: report of the ninth meeting of the WHO alliance for the global elimination of blinding trachoma. Geneva: WHO; 2004. WHO document WHO/PBD/GET/05.1.
5. Bowman RJ, Faal H, Myatt M, Adegbola R, Foster A, Johnson GJ, et al. Longitudinal study of trachomatous trichiasis in the Gambia. Br J Ophthalmol 2002;86:339-43.
6. Burton M, Bowman RJ, Faal H, Aryee EA, Ikumapayi UN, Alexander NDE, et al. The long-term natural history of trachomatous trichiasis in the Gambia. Invest Ophthalmol Vis Sci 2006;47:847-52.
7. Reacher MH, Munoz B, Alghassany A, Daar AS, Elbualy M, Taylor HR. A controlled trial of surgery for trachomatous trichiasis of the upper lid. Arch Ophthalmol 1992;110:667-74.
8. Burton MJ, Kinteh F, Jallow O, Sillah A, Bah M, Faye M, et al. A randomised controlled trial of azithromycin following surgery for trachomatous trichiasis in the Gambia. Br J Ophthalmol 2005;89:1282-8.
9. Adamu Y, Alemayehu W. A randomized clinical trial of the success rates of bilamellar tarsal rotation and tarsotomy for upper eyelid trachomatous trichiasis. Ethiop Med J 2002;40:107-14.
10. Alemayehu W, Melese M, Bejiga A, Worku A, Kebede W, Fantaye D. Surgery for trichiasis by ophthalmologists versus integrated eye care workers: a randomized trial. Ophthalmology 2004;111:578-84.
11. Negrel AD, Chami-Khazraji Y, Arrache ML, Ottmani S, Mahjour J. Qualité de la chirurgie du trichiasis au royaume du Maroc. [The quality of trichiasis surgery in the kingdom of Morocco]. Santé 2000;10:81-92.
12. Bowman RJ, Faal H, Jatta B, Myatt M, Foster A, Johnson GJ, et al. Longitudinal study of trachomatous trichiasis in the Gambia: barriers to acceptance of surgery. Invest Ophthalmol Vis Sci 2002;43:936-40.
13. Bowman RJ, Soma OS, Alexander N, Milligan P, Rowley J, Faal H, et al. Should trichiasis surgery be offered in the village? A community randomised trial of village vs. health centre-based surgery. Trop Med Int Health 2000;5:528-33.
14. West ES, Mkocha H, Munoz B, Mabey D, Foster A, Bailey R, et al. Risk factors for postsurgical trichiasis recurrence in a trachoma-endemic area. Invest Ophthalmol Vis Sci 2005;46:447-53.
15. Burton MJ, Bowman RJ, Faal H, Aryee EA, Ikumapayi UN, Alexander NDE, et al. Long term outcome of trichiasis surgery in the Gambia. Br J Ophthalmol 2005;89:575-9.
16. Khandekar R, Mohammed AJ, Courtright P. Recurrence of trichiasis: a longterm follow-up study in the Sultanate of Oman. Ophthalmic Epidemiol 2001;8:155-61.
17. Zhang H, Kandel RP, Sharma B, Dean D. Risk factors for recurrence of postoperative trichiasis: implications for trachoma blindness prevention. Arch Ophthalmol 2004;122:511-6.
18. Mabey D, Fraser-Hurt N, Powell C. Antibiotics for trachoma. Cochrane Database of Systematic Reviews 2005;2:CD001860.
19. Solomon AW, Peeling RW, Foster A, Mabey DC. Diagnosis and assessment of trachoma. Clin Microbiol Rev 2004;17:982-1011.
20. Bowman RJ, Sillah A, Van Dehn C, Goode VM, Muquit M, Johnson GJ, et al. Operational comparison of single-dose azithromycin and topical tetracycline for trachoma. Invest Ophthalmol Vis Sci 2000;41:4074-9.
21. Schachter J, West SK, Mabey D, Dawson CR, Bobo L, Bailey R, et al. Azithromycin in control of trachoma. Lancet 1999;354:630-5.
22. Whitty CJ, Glasgow KW, Sadiq ST, Mabey DC, Bailey R. Impact of community-based mass treatment for trachoma with oral azithromycin on general morbidity in Gambian children. Pediatr Infect Dis J 1999;18:955-8.
23. Lietman T, Porco T, Dawson C, Blower S. Global elimination of trachoma: how frequently should we administer mass chemotherapy? Nat Med 1999;5:572-6.
24. Solomon AW, Holland MJ, Burton MJ, West SK, Alexander ND, Aguirre A, et al. Strategies for control of trachoma: observational study with quantitative PCR. Lancet 2003;362:198-204.
25. Burton MJ, Holland MJ, Makalo P, Aryee EA, Alexander ND, Sillah A, et al. Re-emergence of Chlamydia trachomatis infection after mass antibiotic treatment of a trachoma-endemic Gambian community: a longitudinal study. Lancet 2005;365:1321-8.
26. Solomon AW, Holland MJ, Alexander ND, Massae PA, Aguirre A, Natividad-Sancho A, et al. Mass treatment with single-dose azithromycin for trachoma. N Engl J Med 2004;351:1962-71.
27. West SK, Munoz B, Mkocha H, Holland MJ, Aguirre A, Solomon, AW, et al. Infection with Chlamydia trachomatis after mass treatment of a trachoma hyperendemic community in Tanzania: a longitudinal study. Lancet 2005;366:1296-300.
28. Emerson PM, Cairncross S, Bailey RL, Mabey DC. Review of the evidence base for the 'F' and 'E' components of the SAFE strategy for trachoma control. Trop Med Int Health 2000;5:515-27.
29. Taylor HR, Velasco FM, Sommer A. The ecology of trachoma: an epidemiological study in southern Mexico. Bull World Health Organ 1985;63:559-67.
30. Taylor HR, West SK, Mmbaga BB, Katala SJ, Turner V, Lynch M, et al. Hygiene factors and increased risk of trachoma in central Tanzania. Arch Ophthalmol 1989;107:1821-5.
31. West SK, Munoz B, Turner VM, Mmbaga BB, Taylor HR. The epidemiology of trachoma in central Tanzania. Int J Epidemiol 1991;20:1088-92.
32. McCauley AP, Lynch M, Pounds MB, West S. Changing water-use patterns in a water-poor area: lessons for a trachoma intervention project. Soc Sci Med 1990;31:1233-8.
33. Lynch M, West SK, Munoz B, Kayongoya A, Taylor HR, Mmbaga BB. Testing a participatory strategy to change hygiene behaviour: face washing in central Tanzania. Trans R Soc Trop Med Hyg 1994;88:513-7.
34. Bailey R, Downes B, Downes R, Mabey D. Trachoma and water use; a case-control study in a Gambian village. Trans R Soc Trop Med Hyg 1991;85:824-8.
35. West S, Munoz B, Lynch M, Kayongoya A, Chilangwa Z, Mmbaga BB, et al. Impact of face-washing on trachoma in Kongwa, Tanzania. Lancet 1995;345:155-8.
36. Emerson PM, Lindsay SW, Walraven GE, Faal H, Bogh C, Lowe K, et al. Effect of fly control on trachoma and diarrhoea. Lancet 1999;353:1401-3.
37. Emerson PM, Bailey RL, Mahdi OS, Walraven GE, Lindsay SW. Transmission ecology of the fly Musca sorbens, a putative vector of trachoma. Trans R Soc Trop Med Hyg 2000;94:28-32.
38. Emerson PM, Bailey RL, Walraven GE, Lindsay SW. Human and other faeces as breeding media of the trachoma vector Musca sorbens. Med Vet Entomol 2001;15:314-20.
39. Emerson PM, Lindsay SW, Alexander N, Bah M, Dibba SM, Faal HB, et al. Role of flies and provision of latrines in trachoma control: cluster-randomised controlled trial. Lancet 2004;363:1093-8.
40. Mathur GM, Sharma R. Influence of some socio-economic factors on the prevalence of trachoma. Indian J Med Sci 1970;24:325-34.
41. Tielsch JM, West KP, Jr, Katz J, Keyvan-Larijani E, Tizazu T, Schwab L, et al. The epidemiology of trachoma in southern Malawi. Am J Trop Med Hyg 1988; 38:393-9.
42. West S, Lynch M, Turner V, Munoz B, Rapoza P, Mmbaga BB, et al. Water availability and trachoma. Bull World Health Organ 1989;67:71-5.
43. Dolin PJ, Faal H, Johnson GJ, Minassian D, Sowa S, Day S, et al. Reduction of trachoma in a sub-Saharan village in absence of a disease control programme. Lancet 1997;349:1511-2.
44. Hoechsmann A, Metcalfe N, Kanjaloti S, Godia H, Mtambo O, Chipeta T, et al. Reduction of trachoma in the absence of antibiotic treatment: evidence from a population-based survey in Malawi. Ophthalmic Epidemiol 2001;8:145-53.
45. United Nations Millennium Project. Investing in development: a practical plan to achieve the Millennium Development Goals. New York: United Nations; 2005.
46. Kuper H, Solomon AW, Buchan JC, Zondervan M, Mabey D, Foster A. Participatory evaluations of trachoma control programmes in eight countries. Trop Med Int Health 2005;10:764-72.